1.275 USD
+0.02 (+2%)
CELU gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. CELU has a bad profitability rating. Also its financial health evaluation is rather negative. CELU is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- CELU had negative earnings in the past year.
- CELU had a negative operating cash flow in the past year.
- In the past 5 years CELU reported 4 times negative net income.
- In the past 5 years CELU always reported negative operating cash flow.
1.2 Ratios
- CELU's Return On Assets of -70.65% is on the low side compared to the rest of the industry. CELU is outperformed by 62.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -70.65% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-58.77%
ROA(5y)-40.28%
ROE(3y)-375.51%
ROE(5y)-245.63%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- CELU has a better Gross Margin (50.61%) than 75.81% of its industry peers.
- In the last couple of years the Gross Margin of CELU has grown nicely.
- The Profit Margin and Operating Margin are not available for CELU so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 50.61% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.74%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- CELU does not have a ROIC to compare to the WACC, probably because it is not profitable.
- CELU has more shares outstanding than it did 1 year ago.
- CELU has more shares outstanding than it did 5 years ago.
- CELU has a worse debt/assets ratio than last year.
2.2 Solvency
- Based on the Altman-Z score of -13.31, we must say that CELU is in the distress zone and has some risk of bankruptcy.
- With a Altman-Z score value of -13.31, CELU is not doing good in the industry: 77.33% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -13.31 |
ROIC/WACCN/A
WACC6.14%
2.3 Liquidity
- A Current Ratio of 0.16 indicates that CELU may have some problems paying its short term obligations.
- CELU has a worse Current ratio (0.16) than 93.52% of its industry peers.
- CELU has a Quick Ratio of 0.16. This is a bad value and indicates that CELU is not financially healthy enough and could expect problems in meeting its short term obligations.
- CELU's Quick ratio of 0.12 is on the low side compared to the rest of the industry. CELU is outperformed by 93.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.16 | ||
| Quick Ratio | 0.12 |
3. Growth
3.1 Past
- The earnings per share for CELU have decreased strongly by -119.42% in the last year.
- Looking at the last year, CELU shows a very negative growth in Revenue. The Revenue has decreased by -15.81% in the last year.
- CELU shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.47% yearly.
EPS 1Y (TTM)-119.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.97%
Revenue 1Y (TTM)-15.81%
Revenue growth 3Y36.47%
Revenue growth 5YN/A
Sales Q2Q%-43.16%
3.2 Future
- The Earnings Per Share is expected to decrease by -119.65% on average over the next years. This is quite bad
- The Revenue is expected to grow by 98.27% on average over the next years. This is a very strong growth
EPS Next Y-752.63%
EPS Next 2Y-119.65%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year27.37%
Revenue Next 2Y49.72%
Revenue Next 3Y144.15%
Revenue Next 5Y98.27%
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for CELU. In the last year negative earnings were reported.
- Also next year CELU is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A cheap valuation may be justified as CELU's earnings are expected to decrease with -119.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-119.65%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- CELU does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
CELULARITY INC-A / CELU FAQ
What is the ChartMill fundamental rating of CELULARITY INC-A (CELU) stock?
ChartMill assigns a fundamental rating of 1 / 10 to CELU.
What is the valuation status of CELULARITY INC-A (CELU) stock?
ChartMill assigns a valuation rating of 0 / 10 to CELULARITY INC-A (CELU). This can be considered as Overvalued.
How profitable is CELULARITY INC-A (CELU) stock?
CELULARITY INC-A (CELU) has a profitability rating of 1 / 10.
What is the financial health of CELULARITY INC-A (CELU) stock?
The financial health rating of CELULARITY INC-A (CELU) is 0 / 10.
What is the earnings growth outlook for CELULARITY INC-A?
The Earnings per Share (EPS) of CELULARITY INC-A (CELU) is expected to decline by -752.63% in the next year.